Medicinal Mushrooms Global Market Opportunities and Strategies to 2035

This report describes and explains the medicinal mushrooms market and covers 2020-2025, termed the historic period, and 2025-2030, 2035F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.

The global medicinal mushrooms market reached a value of nearly $41.78 billion in 2025, having grown at a compound annual growth rate (CAGR) of 9.3% since 2020. The market is expected to grow from $41.78 billion in 2025 to $62.46 billion in 2030 at a rate of 8.4%. The market is then expected to grow at a CAGR of 7.9% from 2030 and reach $91.18 billion in 2035.

Growth in the historic period resulted from growth of nutraceutical and dietary supplements market, expansion of plant-based and alternative medicine trends, rising demand for functional foods and beverages and adoption of traditional Chinese medicine (TCM) and ayurveda. Factors that negatively affected growth in the historic period were regulatory complexity across regions and contamination and quality control risks.

Going forward, increasing awareness of preventive healthcare and immunity, e-commerce and direct-to-consumer expansion, growing demand for clean-label and natural ingredients and increasing use in pharmaceutical and therapeutic applications will drive the growth. Factors that could hinder the growth of the medicinal mushrooms market in the future include high cultivation and processing costs, lack of standardization and scientific validation and impact of trade war and tariffs.

Market trends for the medicinal mushrooms market include sustainability, climate tech and circular economy, industry 4.0, 5 and intelligent manufacturing, biotechnology, genomics and precision medicine, artificial intelligence and autonomous intelligence and digitalization, cloud, big data and cybersecurity.

The medicinal mushrooms market is segmented by type into shiitake, reishi, maitake, chaga, cordyceps, turkey tail, lion’s mane mushroom and other types. The reishi market was the largest segment of the medicinal mushrooms market segmented by type, accounting for 29.4% or $12.28 billion of the total in 2025. Going forward, the cordyceps segment is expected to be the fastest-growing segment in the medicinal mushrooms market segmented by type, at a CAGR of 10.2% during 2025-2030.

The medicinal mushrooms market is segmented by form into fresh, dried and other forms. The fresh was the largest segment of the medicinal mushrooms market segmented by form, accounting for 65.7% or $27.44 billion of the total in 2025. Going forward, the dried segment is expected to be the fastest-growing segment in the medicinal mushrooms market segmented by form, at a CAGR of 9.9% during 2025-2030.

The medicinal mushrooms market is segmented by application into antioxidants, immune enhancer, anti-cancer, skin care and other applications. The immune enhancer market was the largest segment of the medicinal mushrooms market segmented by application, accounting for 33.3% or $13.91 billion of the total in 2025. Going forward, the other applications segment is expected to be the fastest-growing segment in the medicinal mushrooms market segmented by application, at a CAGR of 9.1% during 2025-2030.

The medicinal mushrooms market is segmented by distribution channel into supermarkets and hypermarkets, convenience stores and e-commerce. The supermarkets and hypermarkets market was the largest segment of the medicinal mushrooms market segmented by distribution channel, accounting for 37.7% or $15.74 billion of the total in 2025. Going forward, the e-commerce segment is expected to be the fastest-growing segment in the medicinal mushrooms market segmented by distribution channel, at a CAGR of 11.2% during 2025-2030.

Asia Pacific was the largest region in the medicinal mushrooms market, accounting for 42.5% or $17.76 billion of the total in 2025. It was followed by North America, Western Europe and then the other regions. Going forward, the fastest-growing regions in the medicinal mushrooms market will be Asia Pacific and North America where growth will be at CAGRs of 8.8% and 8.5% respectively. These will be followed by Western Europe and Africa where the markets are expected to grow at CAGRs of 7.8% and 7.7% respectively.

The global medicinal mushrooms market is highly fragmented, with a large number of small players operating in the market. The top 10 competitors in the market made up 1.98% of the total market in 2024. Monterey Mushrooms LLC was the largest competitor with a 0.89% share of the market, followed by Nature's Way Brands LLC with 0.32%, DXN Holdings Bhd with 0.20%, Gaia Herbs Inc with 0.19%, Gourmet Mushrooms Inc with 0.15%, Bio‑Botanica Inc with 0.12%, M2 Ingredients with 0.04%, Far West Fungi with 0.03%, Four Sigmatic Foods Inc with 0.03% and Hirano Mushroom LLC with 0.02%.

The top opportunities in the medicinal mushrooms market segmented by type will arise in the reishi segment, which will gain $5.43 billion of global annual sales by 2030. The top opportunities in the medicinal mushrooms market segmented by form will arise in the fresh segment, which will gain $12.32 billion of global annual sales by 2030. The top opportunities in the medicinal mushrooms market segmented by application will arise in the immune enhancer segment, which will gain $6.97 billion of global annual sales by 2030. The top opportunities in the medicinal mushrooms market segmented by distribution channel will arise in the supermarkets and hypermarkets segment, which will gain $6.85 billion of global annual sales by 2030. The medicinal mushrooms market size will gain the most in the USA at $5.28 billion.

Player-adopted strategies in the medicinal mushrooms market include focus on strengthening operational capabilities through new facility investments and focus on strengthening business operations through new launches.

Market-trend-based strategies for the medicinal mushrooms market include focus on integration of mushrooms in ready-to-consume products, focus on rising investments in medicinal mushroom startups, focus on next-generation mushroom processing solutions, focus on development of innovative nootropic ingredient and development of innovative value-added nutraceutical products.

To take advantage of the opportunities, the analyst recommends the medicinal mushrooms companies to focus on experiential retail and functional beverage integration, focus on investment-led biotechnology expansion, focus on advanced processing technologies for high-potency ingredients, focus on targeted functional formulations for cognitive wellness, focus on data-driven cultivation and knowledge-led product innovation, focus on cordyceps to capture high-growth performance segment, focus on dried products to capture high-growth scalable demand, focus on premium pharmaceutical grade to capture high-value growth, focus on beta-glucan standardization to capture high-growth functional demand, focus on premium pricing strategy to maximize value growth, expand in emerging markets, continue to focus on developed markets, focus on expanding multi-channel distribution for medicinal mushrooms, focus on value-based tiered pricing to capture diverse demand, focus on building category awareness and trust at scale, focus on targeted promotion to drive conversion and loyalty, focus on e-commerce expansion to capture high-growth demand and focus on high-growth emerging applications to drive diversification.

This product will be delivered within 3-5 business days.